Drug Trial Radar · NCT01893190
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Last checked: Nov 19, 2026Latest source record: Feb 5, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
73
Actual
Start
Sep 2013
Primary completion
Jan 2016
Study completion Jan 2016
Sponsor
- Lead sponsor
- Edge Therapeutics IncIndustry
- Sponsor type
- Industry
- First posted
- Jul 8, 2013
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Phase 1/2a Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinetic Study Comparing EG-1962 and Nimodipine in Patients with Aneurysmal Subarachnoid Hemorrhage
Conditions
- Ruptured Cerebral Aneurysm
- Ruptured Berry Aneurysm
Interventions
NimodipineDrug
Based upon Investigator Judgement
Nimodipine MicroparticlesDrug
Based upon Investigator Judgement
Primary outcomes
What the sponsor says the trial is designed to measure.
- Dose Escalation PeriodTime frame: 3 Months
Locations
23 sites in 4 countries. Site status is shown where the registry gives one.
Barrow Neurological Institute
Phoenix, Arizona
Ronald Reagan UCLA Medical Center
Los Angeles, California
Rush University Medical Center
Chicago, Illinois
University of Maryland Medical Cnter
Baltimore, Maryland
Hackensack University Medical Center
Hackensack, New Jersey
Overlook Medical Center
Summit, New Jersey
University of New Mexico
Albuquerque, New Mexico
Mount Sinai Medical Center
New York, New York
Columbia University
New York, New York
Lenox Hill Hospital
New York, New York
Duke University Medical Center
Durham, North Carolina
Mayfield Clinic Inc
Cincinnati, Ohio
The Cleveland Clinic Foundation
Cleveland, Ohio
Oregon Health and Science University
Portland, Oregon
Medical University of South Carolina (MUSC)
Charleston, South Carolina
Vanderbilt University
Nashville, Tennessee
University of Calgary, Foothills Medical Centre
Calgary, Alberta, Canada
University of Alberta Hospital
Edmonton, Alberta, Canada
St. Michael's Hospital
Toronto, Ontario, Canada
University Health Network - Toronto General Division, Toronto Western Hospital
Toronto, Ontario, Canada
University of Saskatchewan, Royal University Hospital
Saskatoon, Saskatchewan, Canada
Charles University, Department of Neurosurgery
Prague, Czechia
Helsinki University Central Hospital
Helsinki, Finland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.